Pacira BioSciences (PCRX) Tax Provisions (2013 - 2026)

Pacira BioSciences' Tax Provisions history runs 14 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 46.53% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $8.0 million (down 77.5% YoY), while the FY2025 annual figure was $9.8 million, down 73.01% from the prior year.
• Tax Provisions was $2.1 million for Q1 2026 at Pacira BioSciences, up from -$1.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $17.7 million in Q2 2024 to a low of -$8.0 million in Q4 2022.
• Historically, Tax Provisions has averaged $3.9 million across 5 years, with a median of $3.9 million in 2025.
• Biggest YoY gain for Tax Provisions was 467.39% in 2023; the steepest drop was 1588.84% in 2023.
• A 5-year view of Tax Provisions shows it stood at -$8.0 million in 2022, then jumped by 211.1% to $8.8 million in 2023, then climbed by 7.18% to $9.5 million in 2024, then slumped by 111.24% to -$1.1 million in 2025, then jumped by 295.31% to $2.1 million in 2026.
• The last three Tax Provisions figures came in at $2.1 million (Q1 2026), -$1.1 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.